IART
Integra LifeSciences HoldingsNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$727.15M
P/E Ratio
—
EPS
$-6.74
Beta
1.06
52W High
$19.13
52W Low
$8.70
50-Day MA
$10.41
200-Day MA
$12.61
Dividend Yield
—
Profit Margin
-31.60%
Forward P/E
4.07
PEG Ratio
0.67
About Integra LifeSciences Holdings
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, limb reconstruction, orthopedics, and general surgery. The company is headquartered in Princeton, New Jersey.
Fundamentals
| Revenue (TTM) | $1.64B |
| Gross Profit (TTM) | $919.42M |
| EBITDA | $297.75M |
| Operating Margin | 12.40% |
| Return on Equity | -39.90% |
| Return on Assets | 2.39% |
| Revenue/Share (TTM) | $21.33 |
| Book Value | $13.40 |
| Price-to-Book | 0.71 |
| Price-to-Sales (TTM) | 0.45 |
| EV/Revenue | 1.536 |
| EV/EBITDA | 15.34 |
| Quarterly Earnings Growth (YoY) | 0.40% |
| Quarterly Revenue Growth (YoY) | -1.70% |
| Shares Outstanding | $77.94M |
| Float | $58.96M |
| % Insiders | 13.93% |
| % Institutions | 98.03% |
Analyst Ratings
Consensus ($15.57 target)
1
Strong Buy2
Buy4
Hold2
Sell2
Strong SellData last updated: 4/8/2026